Stock listing

Cboe Canada:TLT Theralase Technologies Inc. Stock

Canadian listing (Cboe Canada) of Theralase Technologies Inc. · home listing TSXV:TLT

Follow Theralase Technologies Inc. into a list and get an email when it puts out news.

Home listing price · TSXV:TLT

$0.185 CAD 0.000 (0.0%)

Close on Oct 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, TSXV:TLT

Past 3 months -31.5% · daily closes, Jul 6, 2026 – Oct 20, 2026, adjusted for splits

Day range: $0.185 – $0.185 CADOct 20, 2026
Volume: 10,002 sharesOct 20, 2026
Market cap: $57.44M CADAt the close on Oct 20, 2026 · price × 310.5M shares outstanding

Prices by listing

Listing	Last	Change	Volume	Open	High	Low	Previous close	Price from
TSXV:TLT · Home	$0.185 CAD	0.000 (0.0%)	10,002	$0.185	$0.185	$0.185	$0.185	Close on Oct 20, 2026
OTC:TLTFF	$0.133 USD	-0.002 (-1.8%)	11,250	$0.144	$0.144	$0.133	$0.135	Close on Oct 19, 2026
Frankfurt:TTX	€0.103 EUR	0.000 (0.0%)	—	€0.103	€0.103	€0.103	€0.103	Close on Oct 20, 2026
Stuttgart:TTX	€0.112 EUR	+0.004 (+3.7%)	—	€0.103	€0.112	€0.103	€0.108	Close on Oct 19, 2026

Daily closes

Last 3 months, Jul 20, 2026 – Oct 20, 2026 · TSXV:TLT · CAD, adjusted for splits

Day	Close	Change	%	Open	High	Low	Volume
Tue, Oct 20	$0.185	0.000	0.0%	$0.185	$0.185	$0.185	10,002
Mon, Oct 19	$0.185	0.000	0.0%	$0.185	$0.190	$0.185	12,190
Fri, Oct 16	$0.185	-0.005	-2.6%	$0.190	$0.190	$0.180	43,568
Thu, Oct 15	$0.190	0.000	0.0%	$0.195	$0.195	$0.190	62,142
Wed, Oct 14	$0.190	+0.010	+5.6%	$0.185	$0.190	$0.180	68,502
Tue, Oct 13	$0.180	0.000	0.0%	$0.180	$0.185	$0.175	184,605
Fri, Oct 9	$0.180	0.000	0.0%	$0.180	$0.180	$0.180	132,100
Thu, Oct 8	$0.180	0.000	0.0%	$0.180	$0.180	$0.180	216,000
Wed, Oct 7	$0.180	0.000	0.0%	$0.190	$0.190	$0.180	27,200
Tue, Oct 6	$0.180	-0.010	-5.3%	$0.190	$0.190	$0.180	162,500
Mon, Oct 5	$0.190	+0.010	+5.6%	$0.190	$0.190	$0.180	71,500
Fri, Oct 2	$0.180	0.000	0.0%	$0.180	$0.180	$0.180	9,700
Thu, Oct 1	$0.180	0.000	0.0%	$0.180	$0.180	$0.170	176,600
Wed, Sep 30	$0.180	0.000	0.0%	$0.180	$0.180	$0.180	135,100
Tue, Sep 29	$0.180	0.000	0.0%	$0.180	$0.180	$0.180	31,700
Mon, Sep 28	$0.180	0.000	0.0%	$0.180	$0.180	$0.170	63,800
Fri, Sep 25	$0.180	0.000	0.0%	$0.180	$0.180	$0.170	71,400
Thu, Sep 24	$0.180	0.000	0.0%	$0.180	$0.180	$0.170	76,600
Wed, Sep 23	$0.180	0.000	0.0%	$0.180	$0.180	$0.180	81,100
Tue, Sep 22	$0.180	-0.010	-5.3%	$0.190	$0.190	$0.180	306,000
Mon, Sep 21	$0.190	0.000	0.0%	$0.190	$0.190	$0.180	179,000
Fri, Sep 18	$0.190	0.000	0.0%	$0.190	$0.190	$0.180	315,400
Thu, Sep 17	$0.190	0.000	0.0%	$0.190	$0.190	$0.190	64,700
Wed, Sep 16	$0.190	+0.010	+5.6%	$0.190	$0.190	$0.190	14,600
Tue, Sep 15	$0.180	0.000	0.0%	$0.200	$0.200	$0.180	305,100
Mon, Sep 14	$0.180	-0.010	-5.3%	$0.190	$0.190	$0.180	184,600
Fri, Sep 11	$0.190	0.000	0.0%	$0.190	$0.190	$0.190	30,100
Thu, Sep 10	$0.190	0.000	0.0%	$0.190	$0.190	$0.180	576,900
Wed, Sep 9	$0.190	0.000	0.0%	$0.190	$0.190	$0.190	132,400
Tue, Sep 8	$0.190	0.000	0.0%	$0.190	$0.190	$0.190	7,200
Fri, Sep 4	$0.190	+0.010	+5.6%	$0.190	$0.190	$0.190	177,000
Thu, Sep 3	$0.180	-0.010	-5.3%	$0.190	$0.190	$0.180	197,600
Wed, Sep 2	$0.190	0.000	0.0%	$0.180	$0.200	$0.180	278,000
Tue, Sep 1	$0.190	+0.010	+5.6%	$0.180	$0.190	$0.180	250,000
Mon, Aug 31	$0.180	-0.010	-5.3%	$0.190	$0.190	$0.180	229,000
Fri, Aug 28	$0.190	+0.010	+5.6%	$0.180	$0.190	$0.180	248,300
Thu, Aug 27	$0.180	-0.010	-5.3%	$0.180	$0.190	$0.180	326,600
Wed, Aug 26	$0.190	0.000	0.0%	$0.190	$0.200	$0.180	496,500
Tue, Aug 25	$0.190	0.000	0.0%	$0.190	$0.190	$0.190	559,100
Mon, Aug 24	$0.190	0.000	0.0%	$0.190	$0.200	$0.190	326,600
Fri, Aug 21	$0.190	0.000	0.0%	$0.200	$0.200	$0.190	344,700
Thu, Aug 20	$0.190	+0.010	+5.6%	$0.180	$0.200	$0.180	375,400
Wed, Aug 19	$0.180	0.000	0.0%	$0.180	$0.180	$0.180	289,800
Tue, Aug 18	$0.180	-0.010	-5.3%	$0.190	$0.190	$0.180	303,800
Mon, Aug 17	$0.190	0.000	0.0%	$0.180	$0.190	$0.180	554,500
Fri, Aug 14	$0.190	0.000	0.0%	$0.190	$0.190	$0.180	801,000
Thu, Aug 13	$0.190	+0.010	+5.6%	$0.180	$0.190	$0.180	973,700
Wed, Aug 12	$0.180	-0.010	-5.3%	$0.190	$0.190	$0.180	1,071,800
Tue, Aug 11	$0.190	-0.050	-20.8%	$0.200	$0.210	$0.190	1,759,900
Mon, Aug 10	$0.240	-0.030	-11.1%	$0.260	$0.260	$0.240	285,100
Fri, Aug 7	$0.270	+0.010	+3.8%	$0.260	$0.270	$0.260	76,900
Thu, Aug 6	$0.260	0.000	0.0%	$0.270	$0.270	$0.260	17,000
Wed, Aug 5	$0.260	-0.010	-3.7%	$0.270	$0.270	$0.260	65,700
Tue, Aug 4	$0.270	-0.020	-6.9%	$0.300	$0.300	$0.270	141,500
Fri, Jul 31	$0.290	+0.010	+3.6%	$0.280	$0.290	$0.280	152,200
Thu, Jul 30	$0.280	+0.010	+3.7%	$0.270	$0.290	$0.270	110,500
Wed, Jul 29	$0.270	0.000	0.0%	$0.260	$0.270	$0.260	223,100
Tue, Jul 28	$0.270	+0.010	+3.8%	$0.270	$0.270	$0.270	43,000
Mon, Jul 27	$0.260	-0.010	-3.7%	$0.270	$0.270	$0.260	18,500
Fri, Jul 24	$0.270	+0.010	+3.8%	$0.270	$0.280	$0.270	79,500
Thu, Jul 23	$0.260	0.000	0.0%	$0.260	$0.260	$0.260	22,600
Wed, Jul 22	$0.260	0.000	0.0%	$0.260	$0.270	$0.260	16,500
Tue, Jul 21	$0.260	0.000	0.0%	$0.260	$0.260	$0.260	18,000
Mon, Jul 20	$0.260	0.000	0.0%	$0.250	$0.260	$0.250	61,000

Ticker: Cboe Canada:TLT
Asset type: Stock
Sector: Health care
Industry: Biotechnology
Exchange: Cboe Canada
Currency: CAD

What changed lately

Latest news release · Oct 9, 2026
Theralase(R) to Present at ThinkEquity Conference
Latest deck · Oct 15, 2026
Investor Presentation (October 2026)
Investor deck · 16 slides

Latest news

Theralase(R) to Present at ThinkEquity Conference

Oct 9, 2026

Closed $0.18 (0.0%) on Oct 9, 2026

Correcting and Replacing: Theralase(R) Releases Q2 2026 Financial Statements

Sep 18, 2026

Closed $0.19 (0.0%) on Sep 18, 2026

Theralase(R) Commences GLP Toxicology Analysis of Rutherrin(R)

Sep 15, 2026

Closed $0.18 (0.0%) on Sep 15, 2026

Theralase(R) Releases Q2 2026 Financial Statements

Aug 28, 2026

Closed $0.18 (-5.3%) on Aug 31, 2026

Theralase(R) Closes C$3.6 Million Brokered Financing

Aug 24, 2026

Closed $0.19 (0.0%) on Aug 25, 2026

Theralase(R) Announces $5 Million Brokered LIFE Offering

Aug 10, 2026

Closed $0.19 (-20.8%) on Aug 11, 2026

Theralase(R) Engages Global One Media to Expand Global Investor Awareness

Aug 4, 2026

Closed $0.27 (-6.9%) on Aug 4, 2026

Theralase(R) Receives Receipt for C$100 Million Base Shelf Prospectus

Jun 30, 2026

Theralase(R) Lists Warrants on the TSXV

Jun 3, 2026

Theralase(R) Releases Q1 2026 Financial Statements

May 29, 2026

All Theralase Technologies Inc. news

Financings

Private placement of units
Sep 18, 2026
Closed: C$3.56M in the latest tranche · C$0.24 a unit · 1 warrant at C$0.32 · Research Capital Corporation
Dealers: Research Capital Corporation (lead)
Insiders: An aggregate of 116,250 Units, representing gross proceeds of $27,900, were issued to certain insiders of the Company
Use of proceeds: GLP toxicology studies for intravenous Rutherrin in cancers and topical Ruvidar for cold sores; working capital and general corporate purposes
Announced Aug 10, 2026 · Closed Aug 24, 2026 · Closed Aug 28, 2026 · Closed Sep 18, 2026

Read by 6ix AI from the company's releases

Decks

Investor Presentation (October 2026)
Investor deck · 16 slides · Oct 15, 2026
Investor Presentation (February 2026)
Investor deck · 21 slides · Feb 17, 2026
Investor Presentation (November 2025)
Investor deck · 20 slides · Nov 14, 2025
Investor Presentation (June 2025)
Investor deck · 39 slides · Jun 11, 2025

Theralase Technologies Inc. on 6ix

Sector: Health care
Industry: Biotechnology
News releases: 33 in the last 12 months · 241 in all · newest Oct 9, 2026 · oldest 2017
Decks: 12 decks · latest Oct 15, 2026

Where Theralase Technologies Inc. is listed

Listing	Exchange	Country	Currency
TSXV:TLT · Home listing	TSXV	Canada	CAD
OTC:TLTFF	OTC	United States	USD
Cboe Canada:TLT · This page	Cboe Canada	Canada	CAD
Lang & Schwarz:A0DLB7	Lang & Schwarz	Germany	EUR
LS Exchange:A0DLB7	LS Exchange	Germany	EUR
Frankfurt:TTX	Frankfurt	Germany	EUR
Stuttgart:TTX	Stuttgart	Germany	EUR
Dusseldorf:TTX	Dusseldorf	Germany	EUR

Cboe Canada:TLT Theralase Technologies Inc. Stock

Prices by listing

Daily closes

What changed lately

Theralase(R) to Present at ThinkEquity Conference

Investor Presentation (October 2026)

Latest news

Theralase(R) to Present at ThinkEquity Conference

Correcting and Replacing: Theralase(R) Releases Q2 2026 Financial Statements

Theralase(R) Commences GLP Toxicology Analysis of Rutherrin(R)

Theralase(R) Releases Q2 2026 Financial Statements

Theralase(R) Closes C$3.6 Million Brokered Financing

Theralase(R) Announces $5 Million Brokered LIFE Offering

Theralase(R) Engages Global One Media to Expand Global Investor Awareness

Theralase(R) Receives Receipt for C$100 Million Base Shelf Prospectus

Theralase(R) Lists Warrants on the TSXV

Theralase(R) Releases Q1 2026 Financial Statements

Financings

Private placement of units

Decks

Investor Presentation (October 2026)

Investor Presentation (February 2026)

Investor Presentation (November 2025)

Investor Presentation (June 2025)

Theralase Technologies Inc. on 6ix

Where Theralase Technologies Inc. is listed